Eric Tartour

35PUBLICATIONS
203CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsGene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jan 22, 2026
Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Haitham Mirghani, Anne Aupérin, Caroline Even

|Jan 13, 2026
Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.

Sandy Chevrier, Corentin Richard, Olivier Adotévi

|Jul 02, 2025
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapies.

Isabelle Damei, Aziza Caidi, Edouard Auclin

|May 19, 2025
The CD70-CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target.

Ikuan Sam, Nadine Ben Hamouda, Marina Alkatrib

|Mar 28, 2025
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma.

Ikuan Sam, Nadine Benhamouda, Lucie Biard

|Jan 18, 2025
Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variants.

Odile Launay, Rachna Gupta, Tifany Machabert

Pageof 6

Frequent Collaborators

3 joint publications

Stephane Oudard

2 joint publications

Hélène Péré

2 joint publications

Steffen Rickelt

2 joint publications

Elie Marcheteau